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PXPEDITED REVIEW
iagnostic Performance of Multislice Spiral Computed
omography of Coronary Arteries as Compared With
onventional Invasive Coronary Angiography
Meta-Analysis
ichèle Hamon, MD,* Giuseppe G. L. Biondi-Zoccai, MD,§ Patrizia Malagutti, MD,
ierfrancesco Agostoni, MD,¶ Rémy Morello, MD,‡ Marco Valgimigli, MD,† Martial Hamon, MD†
aen, France; Milan, Italy; Rotterdam, the Netherlands; and Antwerp, Belgium
OBJECTIVES This study was designed to define the current role of multislice spiral computed tomography
(MSCT) for the diagnosis of coronary artery disease (CAD) using a meta-analytic process.
BACKGROUND Multislice spiral computed tomography has recently been proposed as an alternative to
conventional coronary angiography (CA) for the diagnosis of CAD.
METHODS Using Medline, we identified 29 studies (2,024 patients) evaluating CAD by means of both
MSCT (16 slices) and conventional CA before July 2006. After data extraction the analysis
was performed according to a random-effects model.
RESULTS The per-segment analysis pooled the results from 27 studies corresponding to a cumulative
number of 22,798 segments. Among unassessable segments, 4.2% were excluded from the
analysis and 6.4% were classified at the discretion of the investigators, underscoring the
shortcomings of MSCT. With this major limitation, the per-segment sensitivity and
specificity were 81% (95% confidence interval [CI] 72% to 89%) and 93% (95% CI 90% to
97%), respectively, with positive and negative likelihood ratios of 21.5 (95% CI 13.1 to 35.5)
and 0.11 (95% CI 0.06 to 0.21), respectively, and positive and negative predictive values of
67.8% (95% CI 57.6% to 78.0%) and 96.5% (95% CI 94.7% to 98.3%), respectively. As
expected, the per-patient analysis has shown an increased sensitivity of 96% (95% CI 94% to
98%) but a decreased specificity of 74% (95% CI 65% to 84%).
CONCLUSIONS Multislice spiral computed tomography has shortcomings difficult to overcome in daily
practice and, at the more clinically relevant per-patient analysis, continues to have moderate
specificity in patients with high prevalence of CAD. Studies evaluating the diagnostic
performance of the newest generation of MSCT, including patients with low to moderate
CAD prevalence, will be critical in establishing the clinical role of this emerging technology
as an alternative to CA. (J Am Coll Cardiol 2006;48:1896–1910) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.028College of Cardiology Foundation
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coronary artery disease (CAD) is the leading cause of death
nd disability in the U.S. and other Western countries.
onventional coronary angiography (CA) is currently the
eference test for coronary artery lumen assessment, and its
se has been steadily increasing over the last decade (1). The
A test comes at a considerable cost and, although com-
lications may be infrequent, cardiac catheterizations ac-
ount for well known procedure-related morbidity (2).
ecent advances in multislice computed tomography
MSCT) seem to respond adequately to the need for a
oninvasive and reliable assessment of the coronary artery
umen. Several studies have compared CA and MSCT;
owever, each of these studies was based on a particularly
imited sample size, meaning that a reliable and unbiased
From the Departments of *Radiology, †Cardiology, and ‡Statistics of the Univer-
ity Hospital of Caen, Caen, Normandy, France; §Hemodynamics and Cardiovascu-
ar Radiology Service, Policlinico San Donato, San Donato Milanese, Milan, Italy;
Radiology Department, Thoraxcenter, Erasmus MC, Rotterdam, the Netherlands;
nd the ¶Cardiovascular Institute Middelheim, AZ Middelheim, Antwerp, Belgium.m
Manuscript received July 5, 2006; revised manuscript received August 16, 2006,
ccepted August 26, 2006.stimate of the performance of MSCT compared with CA
n a reasonably large data set is lacking. To overcome this
ssue and to provide an evidence-based evaluation of the
linical utility of MSCT, we performed a comprehensive
eta-analysis of all currently available studies comparing
SCT and CA for the detection of CAD in native
oronary arteries.
ETHODS
earch strategy. Database searches for English-language
rticles published from January 2002 to July 2006 were
erformed in Medline. We combined the medical subject
eadings for computed tomography, multislice computed
omography, and coronary angiography with the exploded
erm coronary artery disease and scanned references in
etrieved articles and reviews. The retrieved studies were
arefully examined to exclude potentially duplicate or over-
apping data. Meetings abstracts were excluded because they
ould not provide adequately detailed data and their results
ay not have been final. Only papers evaluating the
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyresence of significant obstructive CAD in native coronary
rteries by both conventional invasive CA and MSCT in the
ame subjects were included. Studies were eligible regardless
f whether they referred to subjects with suspected or
roven CAD.
tudy eligibility. We included a study if: 1) it used MSCT
s a diagnostic test for obstructive CAD, with 50%
iameter stenosis selected as the cut-off criterion for signif-
cant CAD, using conventional invasive angiography as the
eference standard; 2) it used the newest generation of
SCT (16 slices); and 3) it reported cases in absolute
umbers of true positive (TP), false positive (FP), true
egative (TN), and false negative (FN) results or presented
ufficiently detailed data for deriving these figures. Studies
ere excluded if they were performed: 1) only in patients
fter coronary artery bypass graft surgery; 2) after percuta-
eous coronary intervention for long-term stent patency
ssessment; 3) in a subset of patients with prior heart
ransplant; or 4) with fewer than 30 enrolled patients.
ata extraction. The following information was extracted
rom each study: first author, year of publication, and
ournal; study population characteristics including sample
ize (number of subjects evaluated with both tests, number
f patients excluded); number of patients with documented
AD; gender; mean age (and standard deviation); mean
eart rate (and standard deviation); relative timing of the 2
maging procedures and whether or not evaluation of one
est was blind to the result of the other and to the clinical
ondition of the tested subject; technical characteristics of
he MSCT, including type and brand of machine used; and
ate of beta-blocker usage. Data were recorded separately,
henever available, at the level of segments, vessels, and
ubjects. Two investigators performed the data extraction
ndependently. Discrepancies were solved by a third inves-
igator and global consensus. The study quality conformed
o the Quadas guidelines (3).
ata synthesis and statistical analysis. Categoric variables
rom individual studies are presented as n/N (%) and
ontinuous variables are presented as median values. Mea-
ures of diagnostic accuracy are reported as point estimates
with 95% confidence intervals [CI]). The main analysis was
erformed at the coronary artery segment level, because
ost studies focused on this level of information. Secondary
Abbreviations and Acronyms
AUC  area under the curve
CA  coronary angiography
FN  false negative
FP  false positive
MSCT  multislice computed tomography
NPV  negative predictive value
PPV  positive predictive value
TN  true negative
TP  true positivenalyses combined the available vessel-level data, consider-ng 4 coronary arteries per patient (left main coronary artery,
eft anterior descending artery, circumflex artery, and right
oronary artery) and patient-level data.
By means of TP, TN, FP, and FN rates we computed
ensitivity, specificity, positive and negative likelihood ra-
ios, and diagnostic odds ratios (4). Although sensitivity and
pecificity are well known as measures of diagnostic accu-
acy, their results may be influenced by the prevalence of
isease in tested subjects. The positive likelihood ratio (the
atio between sensitivity and 1  specificity) provides an
stimate of the probability of a positive test in a patient with
isease, and the negative likelihood ratio (the ratio between
 sensitivity and specificity) gives an estimate of the
robability of a negative test among diseased subjects. Both
ikelihood ratios are roughly independent from prevalence
ates, and there is consensus that a positive likelihood ratio
f 10 and a negative likelihood ratio of 0.1 provide
eliable evidence of satisfactory diagnostic performance (5).
inally, the information from both positive and negative
ikelihood ratios can be combined in a single parameter, the
iagnostic odds ratio, which is computed as the ratio of
ositive to negative likelihood ratios and provides an esti-
ate of how much greater the odds of having the disease are
or the people with a positive test result than for the people
ith a negative test result. Although likelihood ratios are the
ecommended summary statistics for systematic reviews of
iagnostic studies, predictive values may also be of interest
or clinicians, even if these values vary widely in their
ependence on disease prevalence. Such limitations of
redictive values notwithstanding, these figures were also
omputed and reported as exploratory data in this review.
We computed all statistics for individual studies, and
hen combined them using a random-effects model, weight-
ng each point estimate by the inverse of the sum of its
ariance and the between-study variance. Between-study
tatistical heterogeneity was also assessed using the Cochran
chi-square tests. Because diagnostic parameters are by
efinition interdependent, independent weighting mayFigure 1. Flow diagram of the reviewing process.
Table 1. Characteristics of Included Studies
Authors (Ref.)
Slices
(n)
MSCT
(Brand)
Patients
(n)
Excluded
(n)
Male
(%)
Mean Age
(SD) (yrs)
Mean HR (SD)
(beats/min)
Beta-Blockers
(%)
Basis of
Assessment
Unassessable
Segments (%)
Excluded
Segments (%)
Nieman et al. (10) 16 Siemens 59 1 90 58 (12) 56 (6) 58 2.0 mm — —
Hoffmann et al. (11) 16 Siemens 33 0 82 57 (9) 60 (7) 52 All vessels 17 0
Kuettner et al. (12) 16 Siemens 60 0 74 58 (13) 64 (10) 93 All vessels 20 0
Martuscelli et al. (13) 16 GE 64 3 92 58 (5) 59 (5) 100 1.5 mm 16 16
Mollet et al. (14) 16 Siemens 128 1 89 59 (12) 58 (8) 60 2.0 mm 7 0
Cademartiri et al. (15) 16 Siemens 40 0 90 59 (12) 55 (6) 63 2.0 mm 2 0
Hoffmann et al. (16) 16 Philips 103 0 69 62 (10) 69 (12) 100 1.5 mm 6 6
Kaiser et al. (17) 16 Siemens 149 0 74 64 (9) — 69 1.5 mm 23 0
Kuettner et al. (18) 16 Siemens 124 4 100 64 (9) 64 (10) 51 All vessels 21 0
Kuettner et al. (19) 16 Siemens 72 0 59 64 (10) 64 (9) 52 All vessels 13 0
Mollet et al. (20) 16 Siemens 51 0 73 59 (10) 57 (10) 49 2.0 mm — 0
Morgan-Hugues et al. (21) 16 GE 58 1 — 58 (11) 61 (8) — — — 0
Probst et al. (22) 16 Philips 50 4 84 64 (9) — — — — 0
Schuijf et al. (23) 16 Toshiba 45 0 94 63 (10) 65 (10) 78 1.5 mm 6 0
Rodevand et al. (24) 16 Siemens 157 56 63 62 (10) 56 (7) 64 2.0 mm — —
Reant et al. (25) 16 Siemens 40 0 50 70 (9) 65 (9) 25 All vessels 24 24
Nikolaou et al. (26) 16 Siemens 64 4 54 60 (10) 58 (4) 39 Distal excluded 8 8
Garcia et al. (27) 16 Philips 187 0 68 60 (9) 59 (9) — 2.0 mm 29 0
Cordeiro et al. (28) 32 Toshiba 30 0 84 59 (13) 63 (12) 87 1.5 mm 25 25
Lim et al. (29) 40 Philips 30 0 67 59 (10) 61 (10) — All vessels 0 0
Leber et al. (30) 64 Siemens 59 4 — 64 (10) 62 (13) 36 — 0 0
Leschka et al. (31) 64 Siemens 67 0 75 60 (10) 66 (15) 60 1.5 mm 0 0
Mollet et al. (32) 64 Siemens 52 1 65 59 (12) 58 (7) 73 All vessels 0 0
Pugliese et al. (33) 64 Siemens 35 0 60 61 (10) 58 (6) 77 All vessels 3 0
Raff et al. (34) 64 Siemens 70 0 76 59 (11) 65 (10) 100 All vessels 12 12
Schuijf et al. (35) 64 Toshiba 61 1 77 60 (11) 60 (11) 72 All vessels 1 1
Ropers et al. (36) 64 Siemens 84 3 62 58 (10) 59 (9) 74 1.5 mm 4 4
Ehara et al. (37) 64 Siemens 69 2 75 67 (12) 72 (13) 22 All vessels 8 8
Nikolaou et al. (38) 64 Siemens 72 4 82 64 (10) 61 (9) 15 All vessels 10 10
HR  heart rate; SD  standard deviation.
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyometimes give spurious results and provide biased esti-
ates. Weighted symmetric summary receiver-operating
haracteristic plots, with pertinent areas under the curve,
ere computed using the Moses-Shapiro-Littenberg
ethod to overcome this problem of interdependence (6,7).
Sources of clinical and statistical heterogeneity were
xplored by means of subgroup analyses and meta-
egression (7,8). Although the findings of such analyses
hould be regarded mainly as hypothesis generating, statis-
ical significance may suggest substantial changes in the
iagnostic performance of the test under study as the
ovariate increases. Specifically, we performed stratified
er-segment analyses according to publication year, sample
ize, number of interpretable segments, and 16 versus 64
lices.
Statistical computations were performed with SPSS 11.0
SPSS, Chicago, Illinois) and Meta-DiSc (9), and signifi-
ance testing was at the 2-tailed 0.05 level.
ESULTS
he reviewing process is described in Figure 1. Database
earches identified 278 potentially relevant citations. After
itle/abstract assessment, we retrieved 121 studies as com-
lete reports, from which 92 were excluded because: 1) they
id not use MSCT or 16-slice MSCT; 2) they looked
nly at grafts or stent patency or at atherosclerotic plaque
ssessment; 3) they had overlapping data; 4) they were in a
anguage other than English; 5) it was impossible to find or
alculate absolute figures from presented data; or 6) no
ystematic angiographic control was performed. Thus, weigure 2. Plot and table of per-segment sensitivity of multislice computed to
ngiography (CA). CI  confidence interval; df  degrees of freedom.ncluded 29 of these studies in the systematic review
10–38).
All studies were published between January 2002 and July
006. Table 1 presents demographic data and details on
ncluded studies.
er-segment meta-analysis. As shown in Figures 2 to 6,
er-segment analysis pooled results from 27 studies (Table
) (1,865 patients after exclusion of 32 patients because of
nsuccessful MSCT, corresponding to 22,798 segments
fter exclusion of 4.2% of segments) and showed that,
ompared with invasive CA, MSCT had a sensitivity of
1% (95% CI 72% to 89%), a specificity of 93% (95% CI
0% to 97%), a positive likelihood ratio of 21.5 (95% CI
3.1 to 35.5), a negative likelihood ratio of 0.11 (95% CI
.06 to 0.21), and a diagnostic odds ratio of 189.3 (95% CI
3.5 to 383.4). Overall, these summary estimates confirm
he superior (93%) specificity of MSCT in patients under-
oing work-up for suspected CAD, even if this occurs at the
rice of a moderate (81%) value for sensitivity. Indeed, the
igh specificity of MSCT translates into a positive predic-
ive value (PPV) of 67.8% (95% CI 57.6% to 78.0%) and a
egative predictive value (NPV) of 96.5% (95% CI 94.7% to
8.3%), assuming CAD prevalence similar to that found in
he studies included in this review (median value of 63.5%
nd range of 8% to 100%).
Statistical heterogeneity was evident for sensitivity (p 
.001), specificity (p 0.001), positive likelihood ratio (p
.001), negative likelihood ratio (p  0.001), diagnostic
dds ratios (p  0.001), and predictive values (p  0.001),
hich cast a shadow of caution on the previously discussedmography-coronary angiography (MSCT-CA) compared with coronary
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MSCT Versus Conventional Coronary Angiography November 7, 2006:1896–1910ummary estimates, although the use of random-effects
odels throughout should have provided relatively robust
esults even in the presence of statistical inconsistency.
er-vessel meta-analysis. Per-vessel results were reported
n, and thus pooled from, only 8 studies, shown in Table 2
Figure 3. Plot and table of per-segment specificity of Migure 4. Plot and table of per-segment positive likelihood ratio (LR) of MSC2,726 coronary arteries); therefore, meta-analysis should be
iewed in light of the risk of small-study and publication
ias. Per-vessel analysis provided the following results: 82%
95% CI 80% to 85%) sensitivity, 91% (95% CI 90% to
2%) specificity, 11.8 (95% CI 6.7 to 20.6) positive likeli-
-CA compared with CA. Abbreviations as in Figure 2.T-CA compared with CA. Other abbreviations as in Figure 2.
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyood ratios, 0.08 (95% CI 0.02 to 0.32) negative likelihood
atio, and 146.5 (95% CI 31.9 to 671.2) diagnostic odds
atio, with 0.97 symmetric area under the curve. Pooled
PV for per-vessel analysis was 81% (95% CI 78% to 83%),
hereas NPV was 92% (95% CI 91% to 93%). Heteroge-
eity was significant (p  0.001) for all of the aforemen-
ioned diagnostic performance measures.
er-patient meta-analysis. Table 2 shows that somewhat
ncomplete reporting was available for per-patient results
Figure 5. Plot and table of per-segment negative likelihood ratio (LRFigure 6. Plot and table of per-segment diagnostic odds ratio (OR) of Mrom 22 studies (1,616 patients), so the risk of small-study
nd publication bias should not be dismissed. The study of
robst et al. (22) was excluded from the pooled analysis
ecause a 0 value for FP, FN, and TN meant that the
ariance is infinite and confidence intervals could not be
omputed. As shown in Figures 7 to 11, pooled per-patient
nalysis—including 21 studies, corresponding to 1,570 pa-
ients—provided the following results: 96% (95% CI 94% to
8%) sensitivity, 74% (95% CI 65% to 84%) specificity, 5.4
MSCT-CA compared with CA. Other abbreviations as in Figure 2.SCT-CA compared with CA. Other abbreviations as in Figure 2.
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MSCT Versus Conventional Coronary Angiography November 7, 2006:1896–1910able 2. Per-Segment, Per-Vessel, and Per-Patient Analysis
n
TP
(n)
TN
(n)
FP
(n)
FN
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
ieman et al. (10)
Vessels 231 82 125 20 4 95 86 80 97
Patients 58 38 7 13 0 100 35 75 100
offmann et al. (11)
Segments 530 34 457 19 20 63 96 64 96
Patients 33 19 9 3 2 90 75 86 82
uettner et al. (12)
Segments 763 54 667 21 21 72 97 72 97
Patients 60 35 23 1 1 97 96 97 96
artuscelli et al. (13)
Segments 613 83 511 9 10 89 98 90 98
ollet et al. (14)
Segments 1,384 216 1,092 58 18 92 95 79 98
Vessels 517 177 298 31 11 94 91 85 96
Patients 127 106 18 3 0 100 86 97 100
ademartiri et al. (15)
Segments 428 88 322 14 4 96 96 86 99
offmann et al. (16)
Segments 1,296 149 1,117 22 8 95 98 87 99
Vessels 345 92 241 9 3 97 96 91 99
Patients 103 56 38 7 2 97 84 89 95
aiser et al. (17)
Segments 2,110 128 1,532 146 304 30 91 47 83
Vessels 592 151 269 58 114 57 82 72 70
Patients 149 96 18 19 16 86 49 84 53
uettner et al. (18)
Segments 1,560 304 1,172 29 55 85 98 91 96
uettner et al. (19)
Segments 936 96 804 15 21 82 98 86 97
ollet et al. (20)
Segments 610 61 537 9 3 95 98 87 99
Vessels 202 51 143 6 2 96 96 90 99
Patients 51 31 17 3 0 100 85 91 100
organ-Hugues et al. (21)
Segments 675 75 566 19 15 83 97 80 97
Patients 57 32 24 1 0 100 96 97 100
robst et al. (22)
Segments 690 188 424 70 8 96 86 73 98
Patients 46 46 0 0 0 100 100 100 100
chuijf et al. (23)
Segments 317 59 231 22 5 93 91 73 98
odevand et al. (24)
Patients 101 49 15 37 0 100 30 57 100
eant et al. (25)
Segments 458 14 421 19 4 78 96 42 99
Patients 40 12 21 6 1 92 78 67 95
ikolaou et al. (26)
Segments 388 4 380 3 1 80 99 57 100
Patients 60 4 52 3 1 80 95 57 98
arcia et al. (27)
Segments 1,629 79 996 544 10 89 65 13 99
Patients 187 58 70 58 1 98 55 50 99
ordeiro et al. (28)
Segments 263 34 207 13 9 79 94 72 96
im et al. (29)
Segments 459 88 364 6 1 99 98 94 100
eber et al. (30)
Segments 798 90 638 19 51 64 97 83 93
Patients 45 22 17 3 3 88 85 88 85
eschka et al. (31)
Segments 1,005 165 805 24 11 94 97 87 99
Patients 67 47 20 0 0 100 100 100 100Continued on next page
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiography95% CI 3.4 to 8.3) positive likelihood ratio, 0.05 (95% CI
.03 to 0.09) negative likelihood ratio, and 133.05 (95% CI
7.3 to 308.9) diagnostic odds ratio. Pooled PPV for
er-patient analysis was 83% (95% CI 76% to 90%) and
ooled NPV was 94% (95% CI 89% to 99%). Heterogeneity
as again significant (p  0.001) for all of the aforemen-
ioned diagnostic performance measures.
Cumulative results are summarized in Table 3, and quality
ssessment for all included studies is shown in Table 4.
able 2. Continued
n
TP
(n)
TN
(n)
F
(
ollet et al. (32)
Segments 725 93 601
Patients 51 38 12
ugliese et al. (33)
Segments 494 66 408
Patients 35 25 9
aff et al. (34)
Segments 935 79 802
Vessels 279 63 194
Patients 70 38 27
chuijf et al. (35)
Segments 842 62 755
Vessels 239 46 179
Patients 60 29 28
opers et al. (36)
Segments 1,083 39 1,010
Vessels 321 36 263
Patients 81 25 50
hara et al. (37)
Segments 884 275 545
Patients 67 59 6
ikolaou et al. (38)
Segments 923 97 762
Patients 68 38 23
N  false negative; FP  false positive; NPV  negative predictive value; PPV Figure 7. Plot and table of per-patient sensitivity of MSCT-ummary receiver-operating characteristics. Findings for
ndividual diagnostic statistics were confirmed with sum-
ary receiver-operating characteristic curves providing a
ymmetric area under the curve of 0.98 for the per-segment
nalysis (Fig. 12A) and a symmetric area under the curve of
.97 for the per-patient analysis (Fig. 12B).
dditional analyses. We explored sources of clinical and
tatistical heterogeneity by performing per-segment sub-
roup analysis for the number of slices in each CT scan.
FN
(n)
Sensitivity
(%)
Specificity
(%)
PPV
(%)
NPV
(%)
1 99 95 76 100
0 100 92 97 100
1 99 96 78 99
0 100 90 96 100
13 86 95 66 98
6 91 92 80 97
2 95 90 93 93
11 85 98 82 99
7 87 96 82 96
2 94 97 97 93
3 93 97 56 100
2 95 93 64 99
1 96 91 83 98
29 90 94 89 95
1 98 86 98 86
21 82 95 72 97
1 97 79 86 96
ve predictive value; TN  true negative; TP  true positive.P
n)
30
1
19
1
41
16
3
14
7
1
31
20
5
35
1
43
6CA compared with CA. Abbreviations as in Figure 2.
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MSCT Versus Conventional Coronary Angiography November 7, 2006:1896–1910lthough a 64-slice CT scan should be more accurate
han a 16-slice one, we did not find significant results by
nteraction testing at segment level, even if a trend of
.35 (95% CI 0.70 to 15.92; p  0.12) increase in relative
iagnostic odds ratio was noted. Specifically, for 16-slice
T scans, we found a sensitivity of 76% (95% CI 63% to
9%), a specificity of 95% (95% CI 94% to 97%), a 22.7
95% CI 13.7 to 37.8) positive likelihood ratio, a 0.13
95% CI 0.05 to 0.34) negative likelihood ratio, and a
70.8 (95% CI 57.1 to 510.5) diagnostic odds ratio. For
4-slice CT, we found a sensitivity of 87% (95% CI 80%
Figure 8. Plot and table of per-patient specificity of MFigure 9. Plot and table of per-patient positive likelihood ratio (LR) of Mo 94%), a specificity of 96% (95% CI 95% to 97%), a
2.5 (95% CI 17.8 to 28.4) positive likelihood ratio, a
.10 (95% CI 0.06 to 0.20) negative likelihood ratio, and
217.6 (95% CI 117.6 to 402.7) diagnostic odds ratio.
he same analysis at patient level showed that 64-slice
T increases significantly the per-patient diagnostic
ield of the test. Specifically, the increase in relative
iagnostic odds ratio was 6.17 (95% CI 1.27 to 29.97; p
0.026).
Finally, we performed meta-regression analyses exploring
he impact of sample size and publication year on the diagnos-
CA compared with CA. Abbreviations as in Figure 2.SCT-CA compared with CA. Other abbreviations as in Figure 2.
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyic performance of MSCT. Whereas the latter did not disclose
ignificant results, we found a significant interaction between
hanges in sample size and diagnostic odds ratios in the
ndividual studies (p  0.05), suggesting that smaller studies
ere more likely to provide higher diagnostic odds ratios.
lthough it is possible that these results were due to differences
n design, setting, and technique, they may also be indirect
vidence of small study bias.
ISCUSSION
n the present study, we focused on the diagnostic performance
f the newest generation of MSCT (16 slices) to assess the
Figure 10. Plot and table of per-patient negative likelihood ratio (LRFigure 11. Plot and table of per-patient diagnostic odds ratio (OR) of Mxtent and severity of coronary stenoses compared with con-
entional CA. The main analysis was performed at the seg-
ent level, because most studies focused on that level of
nformation. Our meta-analysis confirms the relatively high
93%) specificity of MSCT, which occurs at the price of a
oderate (81%) value for sensitivity. This high specificity of
SCT-CA may be translated in the future into a clinically
seful tool in assessable coronary segments; a high NPV of
6.5% would suggest exclusion of CAD in selected subjects
onsidered for conventional CA. However, these optimistic
gures were provided in highly selected patients and after
xclusion from the analysis of 4.2% of scanned segments, with
MSCT-CA compared with CA. Other abbreviations as in Figure 2.SCT-CA compared with CA. Other abbreviations as in Figure 2.
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MSCT Versus Conventional Coronary Angiography November 7, 2006:1896–1910n additional 6.4% of unassessable segments classified at the
iscretion of the investigators, and favoring the positive per-
igure 12. Plot of symmetric summary per-segment (A) and per-patient
eceiver-operating characteristic curve provides a graphic display of diagno
he vertical axis. The pertinent area under the curve (AUC) and Q* statist
rrors (SE), are also included. SROC  summary receiver-operating chareption of MSCT as a valuable diagnostic tool. In addition to oost hoc exclusion of some segments showing poor image
uality, such as calcium-blooming artifacts, the great majority
eceiver-operating characteristic of MSCT-CA compared with CA. The
curacy by plotting 1  specificity in the horizontal axis and sensitivity in
e point where sensitivity and specificity are maximal), both with standard
stic; other abbreviations as in Figure 2.(B) r
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyn reference vessel size. Keeping in mind this major restriction,
he present meta-analysis demonstrates that MSCT-CA pro-
ides, for the per-segment analysis, across a wide range of
iverse clinical centers, consistent diagnostic performance in a
ighly selected study population.
In our secondary analyses, the results are largely consis-
ent and show the anticipated increase in sensitivity and
ecrease in specificity as one moves from segments to vessels
o subjects. This consistent trend in the diagnostic value is
lso observed with the NPV of 96.5% at segment level
ropping to 94% at patient level and the diagnostic odds
atio of 189.3 (95% CI 93.5 to 383.4) at segment level
ropping to 133.05 (95% CI 57.3 to 308.9) at patient level.
his finding is likely to reflect the fact that studies on
SCT have primarily focused on patients with a high
revalence of CAD, in whom an increase in false-positive
bservations (related mainly to heavy calcification) can be
nticipated, whereas true negative findings are expected to
emain low and essentially unaffected as the analysis moves
rom per-segment to per-patient. However, this major
rawback in reporting data in manuscripts and reporting
ome unassessable segments as negative findings favors the
ositive perception of MSCT when reading reports and in
he present meta-analysis. In real life and in daily practice,
he accuracy of MSCT is certainly decreased by the fact that
ninterpretable segments must be considered as positive to
void misdiagnosis for individuals, especially when these
nassessable segments are proximal and masked by heavy
alcifications. It is noteworthy that the only multicenter
tudy following this rule in the present meta-analysis found
he lowest per-segment specificity, 65%, leading to a spec-
ficity of only 55% at patient level (27).
The trend toward increasing sensitivity and specificity in
oving from 16-slice to 64-slice CT supports active re-
earch in the new generation of CT scanners. From this
erspective, it is noteworthy that some studies (32,33),
ased on the newest generation of 64-slice CT, reported
esults from almost all evaluated segments, irrespective of
essel size and image quality.
Indeed, cardiac imaging using CT is a technically de-
anding task. Not only is high spatial resolution required
or imaging small structures such as the coronary arteries,
ut high temporal resolution must also be achieved for
otion-free imaging of the heart, given heart rates that may
ange from 50 to more than 100 beats/min (39). To
vercome and minimize the effects of this issue, most
nvestigators use beta-blockers, as found in our systematic
able 3. Pooled Summary Results
Analysis n
Sensitivity
(95% CI)
Specificity
(95% CI)
er segment 22,798 0.81 (0.72–0.89) 0.93 (0.90–0.97)
er vessel 2,726 0.82 (0.80–0.85) 0.91 (0.90–0.92)
er patient 1,570 0.96 (0.94–0.98) 0.74 (0.65–0.84)
I  confidence interval; DOR  diagnostic odds ratio; LR  positive likelihooeview and as previously suggested by some reports, which kemonstrated a variation in diagnostic performance accord-
ng to the patient’s heart rate (40). Respiratory motion must
lso be eliminated for cardiac imaging, so scanning must be
erformed in a single breath hold. All of these technical
ssues are critical for optimal acquisition, and even with the
emarkable progress of successive generations of scanners
roviding faster imaging at progressively higher spatial and
emporal resolutions, only highly selected patients can be
xplored by MSCT for CAD assessment.
linical implications and cautionary notes. It should be
mphasized that the observed per-segment high specificity
as been obtained in patients selected to undergo CA and
ho are, therefore, presenting with reasonably high proba-
ility of CAD. The median prevalence of CAD was as high
s 63.5% (95% CI 8% to 100%) among the included studies.
hether the performance of MSCT in terms of negative
redictive value can be reproduced in patients at lower
revalence of CAD remains to be assessed. Moreover,
atients with a high probability of CAD were selected based
n several parameters, including regular and controlled
eart rate, renal function, breath-hold capacity, hemody-
amic status, and, often, previous coronary instrumentation.
his highlights the limited external validity of the present
ndings and calls for studies evaluating the diagnostic
erformance of MSCT in a less highly selected patient
opulation before its application in the clinical setting can
e suggested as an alternative to CA.
The relatively high radiation dose received with MSCT,
ompared with CA, should also be acknowledged. The
ffective radiation dose varies based on the presence of the
ube current modulation, ranging from 5.4 to 16.3 mSv for
6-slice CT and from 10 to 21.4 mSv for 64-slice CT in the
apers where this information was provided. The effective
adiation dose for invasive CA is known to be in the range
f 2 to 5 mSv (41,42).
It is also important to acknowledge that if the MSCT
etection of coronary calcification results frequently in a
alse positive classification when CA fails to identify signif-
cant luminal narrowing in that segment, from a clinical
oint of view this finding adds valuable prognostic infor-
ation. Indeed the presence of coronary calcification has
een associated with future coronary events and can justify
ggressive risk factor reduction therapy (43–45).
tudy limitations. As mentioned in the preceding, sub-
tantial statistical heterogeneity has been documented, cast-
ng a shadow of caution on the results and interpretation of
hese estimates of comprehensive, pooled effects. The well
LR (95% CI) LR (95% CI) DOR (95% CI)
21.54 (13.07–35.48) 0.11 (0.06–0.21) 189.32 (93.47–383.43)
11.80 (6.75–20.64) 0.08 (0.02–0.32) 146.45 (31.95–671.21)
5.36 (3.45–8.33) 0.05 (0.03–0.09) 133.05 (57.29–308.98)
; LR  negative likelihood ratio.nown tendency toward publication bias favoring studies
Table 4. Quality Assessment (QUADAS)
Study Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Item 13 Item 14
Nieman et al. (10) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Hoffmann et al. (11) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Kuettner et al. (12) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Martuscelli et al. (13) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Mollet et al. (14) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Cademartiri et al. (15) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Hoffmann et al. (16) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Kaiser et al. (17) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Kuettner et al. (18) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Kuettner et al. (19) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Mollet et al. (20) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes No Unclear
Morgan-Hugues et al. (21) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Probst et al. (22) No No Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes No Unclear
Schuijf et al. (23) No Unclear Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Rodevand et al. (24) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Reant et al. (25) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Nikolaou et al. (26) Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Garcia et al. (27) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Cordeiro et al. (28) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Lim et al. (29) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Leber et al. (30) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Leschka et al. (31) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Mollet et al. (32) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Pugliese et al. (33) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Raff et al. (34) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No Yes
Schuijf et al. (35) No No Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Ropers et al. (36) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Ehara et al. (37) No Yes Yes Unclear Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Nikolaou et al. (38) No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
Item 1: was the spectrum of patients representative of the patients who will receive the test in practice?; Item 2: were selection criteria clearly described?; Item 3: is the reference standard likely to correctly classify the target condition?;
Item 4: is the time period between reference standard and index test short enough to be reasonably sure that the target condition did not change between the two tests?; Item 5: did the whole sample or a random selection of the sample
receive verification using a reference standard of diagnosis?; Item 6: did patients receive the same reference standard regardless of the index test results?; Item 7: was the reference standard independent of the index test (i.e. the index test
did not form part of the reference standard)?; Item 8: was the execution of the index test described in sufficient detail to permit replication of the test?; Item 9: was the execution of the reference standard described in sufficient detail
to permit its replication?; Item 10: were the index test results interpreted without knowledge of the results of the reference standard?; Item 11: were the reference standard results interpreted without knowledge of the results of the index
test?; Item 12: were the same clinical data available when test results were interpreted as would be available when the test is used in practice?; Item 13: were uninterpretable/intermediate test results reported?; Item 14: were withdrawals
from the study explained?
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November 7, 2006:1896–1910 MSCT Versus Conventional Coronary Angiographyith positive and encouraging results also complicates
omprehensive evaluation. In the present meta-analysis,
ata abstraction and quality assessment were done by
ndependent reviewers and, in the case of any divergences,
esolution was made by consensus. Therefore, the interop-
rator agreement could not be quantitatively assessed. We
hould also acknowledge that not all reports provided
omplete data concerning subject and vessel levels. More
igorous reporting of future clinical research on coronary
rtery imaging technologies should be encouraged.
ONCLUSIONS
ultislice spiral computed tomography has shortcomings
ifficult to overcome in daily practice and, at the more
linically relevant per-patient analysis, remains with mod-
rate specificity in patients with high prevalence of CAD.
ndeed, an increase in sensitivity and a decrease in specificity
s one moves from segments to vessels to patients have been
bserved in existing studies, with a subset of patients with
igh prevalence of CAD selected to validate the MSCT
iagnostic performance. Studies evaluating the diagnostic
erformance of the newest-generation MSCT, including
atients with low to moderate CAD prevalence undergoing
comprehensive coronary artery tree evaluation, will be
ritical in establishing the clinical role of this emerging
echnology as an alternative to CA.
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